Weekly oral alendronate in mevalonate kinase deficiency

BACKGROUND: Mevalonate kinase deficiency (MKD) is caused by mutations in the MVK gene, encoding the second enzyme of mevalonate pathway, which results in subsequent shortage of downstream compounds, and starts in childhood with febrile attacks, skin, joint, and gastrointestinal symptoms, sometimes i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cantarini, Luca, Vitale, Antonio, Magnotti, Flora, Lucherini, Orso Maria, Caso, Francesco, Frediani, Bruno, Galeazzi, Mauro, Rigante, Donato
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2013
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880037/
https://ncbi.nlm.nih.gov/pubmed/24360083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-196
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge